Intec Pharma is a drug development company, applying its innovative proprietary gastric retention technology to develop improved formulations of existing drugs.

The drugs that were selected to be improved had at least one of the following characteristics:

• Low bioavailability
  
  
• Significant side effects
  
  
• Poor efficacy
  
  
• Frequent dosing

Controlled release delivery systems failed to provide a solution for the selected drugs, because they are absorbed primarily through the upper part of the gastrointestinal track.

Intec Pharma targets significant unmet needs for various therapeutic areas, including the central nervous system (CNS), the cardiovascular system, as well as gastrointestinal (GI) and infectious diseases.